Cost analysis of GenoType® MTBDRplus and GenoType® MTBDRsl at the State Laboratory of São Paulo, Brazil
Rev. Soc. Bras. Med. Trop
; 56: e0238, 2023. tab, graf
Article
em En
|
LILACS-Express
| LILACS
| ID: biblio-1449347
Biblioteca responsável:
BR1.1
ABSTRACT
ABSTRACT Background:
We aimed to evaluate the costs of GenoType® MTBDRplus and MTBDRsl incurred during the diagnosis of first- and second-line drug-resistant tuberculosis (TB) in São Paulo, Brazil.Methods:
Mean and activity-based costs of GenoType® were calculated in a referral laboratory for TB in Brazil.Results:
The mean cost value and activity-based cost of GenoType® MTBDRplus were USD 19.78 and USD 35.80 and those of MTBDRsl were USD 54.25 and USD 41.85, respectively.Conclusions:
The cost of GenoType® MTBDRplus was reduced owing to the high number of examinations performed and work optimization.
Texto completo:
1
Índice:
LILACS
Tipo de estudo:
Health_economic_evaluation
País/Região como assunto:
America do sul
/
Brasil
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
MEDICINA TROPICAL
Ano de publicação:
2023
Tipo de documento:
Article
/
Project document